You don't have to be a brain surgeon to use HoloLens apps. Except in this case.
Researchers treated Duchenne muscular dystrophy using the new gene editing breakthrough, CRISPR. It will be some time before human treatment develops, but clinical trials are moving forward.
Over 200,000 people subscribe to our newsletter.
Sign in to join the conversation.